eye issues with tirzepatide Weight-loss drugs Mounjaro Wegovy Ozempic semaglutide increase optic nerve risks in diabetes patients India Has anyone experienced vision issues

rigorous human evidence is limited and individual results vary

These drugs have actually been around for 20 years now, at least for diabetes

Roughly 20 to 30% of users, particularly those with severe chronic degeneration, report minimal improvement

Tirzepatide adds a second mechanism: it also activates the GIP (glucose-dependent insulinotropic polypeptide) receptor, the original incretin identified in the 1970s

B12 vitamins help support a healthy mood (1), brain cell function and reduce fatigue for those low in B12

Animal and Laboratory DSIP Research Preclinical research has explored a wide range of outcomes, often with inconsistent or species-dependent results